Navigate to Other Sector


Healthcare Newsletter – February 2017

Interests Spike in US Opioids Opportunity post New FDA Guidance for Abuse Deterrence
Affordability Qualms Remain a Deal breaker in Rare Disease Medicine Access
US FDA continues to warm up to Biosimilars with the newDraft Guidance on Interchangeability
Home Health Services Emerging as New Avenue for Growth in Medical Devices
Deconstructing the Decline in 2016 US FDA Approvals with a fine-tooth comb

Sathguru Foot Print

Sathguru Announces $ 100 Mn Agri & food PE Fund

  • Building of decades of experience of catalyzing success for clients with unique expertise in strategy, innovation, regulations & corporate finance, Sathguru announces $100 Mm private equity fund for agri & food companies seeking growth capital
  • The fund will invest $8 Mn to $12 Mn per company for a significant minority stake
  • First close expected by mid-2017
  • Click here for more details

Indian Union Budget 2017-18: DECODED

  • With an effort to decode and simplify the amendments of Finance Bill 2017, Sathguru brings to you a summary of the key proposals of the Union Budget 2017-18
  • Click here for the summary

MEDCON 2017 – Delhi, India (March 2017)

  • Sathguru is the knowledge partner for ASSOCHAM’s MEDCON 2017 (Mar 22, 2017) with the theme of innovation in manufacturing, delivery & financing
  • Click here for more details

BIO 2017 (San Diego, CA – June 2017)

  • Look forward to meeting you at the beach or in the convention center (booth 4700). Sathguru’s CEO Vijay is moderating a penel on biologics in crop improvement
  • Click here for more details

Stop by to say hello to us!

Mandates—ongoing assignments and partnering opportunities
1. In-licensing/Acquiring – ANDAs and specialty generics for leading Indian Pharma Company
2. Strategic investments – Leading Israeli CDMO with strong expertise in topical products
3. Private equity fund raising for an Indian diagnostic company
4. Aqua segment opportunity assessment & strategy for animal health company

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons